The biotech company’s pivot into digital assets marks one of the largest treasury financings to date, underscoring growing institutional demand for tokenized finance.
You might also be interested in reading Bitcoin Treasury Firms’ ‘Dry Powder’ Could Push Prices Up Significantly: NYDIG.